The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,018.50 on January 31, 2018, with an ultimate completion date of January 25, 2019. The order carries fixed-price pricing with economic price adjustment and no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order procures analytical laboratory instruments and associated consumables or services, consistent with Agilent's role as a supplier of gas chromatography-mass...
<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $17,948.50 on September 19, 2019, for drugs and biologicals, with ultimate completion on October 19, 2019. Place of performance is Bethesda, Maryland. The order uses firm fixed-price pricing with no set-aside category.</p>
The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $19,429.50 on June 11, 2018, for firm fixed price delivery completing July 6, 2018. Place of performance is Bethesda, Maryland. No set-aside was used. The order procures analytical laboratory instruments, consumables, or maintenance services consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...
<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $17,430.36 on June 21, 2018, with an ultimate completion date of July 23, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order covers analytical laboratory instruments or related consumables and services, consistent with Agilent's product line of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated supplies.</p>
<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $17,430.36 on May 24, 2018, with ultimate completion on June 23, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order procures analytical laboratory instrumentation or consumables; the specific product line is not identified in the award record.</p>
<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $5,124.04 on May 15, 2018, with ultimate completion on June 30, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price.</p>
<p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. valued at $12,914.00 on July 20, 2017, with an ultimate completion date of July 19, 2018. Place of performance is San Diego, California. The order carries firm fixed price pricing with no set-aside designation. The procurement covers analytical laboratory instruments and associated consumables or services typical of Agilent's federal equipment and maintenance portfolio.</p>
The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for a maintenance agreement valued at $17,982.00, effective August 22, 2019, with ultimate completion August 23, 2020. Place of performance is Bethesda, Maryland. The order uses fixed price with economic price adjustment pricing. No set-aside was used. The work covers maintenance services for Agilent analytical laboratory instrumentation, consistent with Agilent's CrossLab maintenance service model sustaining the...
<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $11,383.20 for a maintenance agreement, with an award date of October 31, 2017 and ultimate completion date of November 30, 2018. Performance is located in Bethesda, Maryland. The order is priced firm fixed price with no set-aside category.</p>
The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...